Novo Nordisk sales by therapy area 2021-2023
Danish drug manufacturer Novo Nordisk generated some 215 billion kroner - or nearly 93 percent of its total sales - in the diabetes and obesity care segment. The biopharma/rare disease segment was significantly lower, generating some 17.2 billion kroner of the company's total sales.